Background: Reduction mammoplasty is popular among various age groups, yet the impact of age on postoperative outcomes remains debated. Methods: The ACS-NSQIP (2008-2021) was queried to identify female adult patients who underwent reduction mammoplasty. Patients were categorized into 10-year age brackets (i.e., 18-29, 30-39, 40-49, 50-59, 60-69, and >70 years). We compared age-dependent 30-day outcomes via confounder-adjusted multivariate analyses. Results: 40,958 female patients (mean age: 41 ± 14 years and mean body mass index: 31 ± 6.1 kg/m²) were identified. Complications occurred in 6.4% (n=2,635) of cases, with 770 (1.9%) and 483 (1.2%) patients requiring reoperation and readmission, respectively. 1,706 (4.2%) women experienced surgical complications, while medical complications were generally rare (n=289; 0.7%). Compared to women aged 18-29 years, patients aged 30-39 years (OR: 1.22, p<0.01; OR: 1.05 p=0.51; OR: 1.84, p<0.01), 40-49 years (OR: 1.34, p<0.01; OR: 1.17, p=0.04; OR: 1.54, p=0.03), 50-59 years (OR: 1.45, p<0.01; OR: 1.31, p<0.01; OR: 1.78, p<0.01) 60-69 years (OR: 1.38 years, p<0.01; OR: 1.29, p=0.01; OR: 1.71, p<0.01), and >70 years (OR: 1.25, p=0.18; OR: 1.01, p=0.98; OR: 1.86, p=0.14) all had higher risks of any, surgical and medical complications, respectively. Patients aged >30 years were also more likely to require readmissions and reoperations. Conclusion: Patient age significantly impacts outcomes after reduction mammoplasty, with the lowest risk in patients under 30 years. Importantly, the association between age and postoperative morbidity was not linear. These findings can help guide informed decisions, recognizing that while age is a factor, it is not the sole determinant of risk.